San Diego, CA, United States of America

Penghui Chen

This inventor holds 1 USPTO granted patent. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Penghui Chen. Retrieved from https://idiyas.com/inventor/penghui-chen-41mpo2lh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Penghui Chen and His Patent on Androgen Receptor Modulators

Introduction

Penghui Chen is an inventor based in San Diego, California, and is associated with Ligand Pharmaceuticals, Inc. His patent work concerns compounds and methods for modulating the androgen receptor, a steroid receptor involved in biological processes.

Latest Patents

Chen is credited with 1 patent: “Androgen receptor modulator compounds and methods.” The patent describes compounds, pharmaceutical compositions, and methods for modulating processes mediated by steroid receptors. It focuses on non-steroidal compounds and compositions that act as androgen receptor agonists, partial agonists, or antagonists. It also describes methods for preparing and using key intermediates, including a stereoselective synthetic route for intermediates used to make androgen receptor modulators.

Career Highlights

Chen’s listed patent reflects work in medicinal chemistry and pharmaceutical research, particularly the development and synthesis of compounds that affect androgen receptor activity. His company affiliation is Ligand Pharmaceuticals, Inc.

Collaborations

Robert Higuchi and Barbara A. Pio are identified as Chen’s coworkers. Their shared company affiliation provides context for the professional environment associated with his patent work.

Conclusion

Penghui Chen’s patent documents a contribution to androgen receptor research through non-steroidal modulators, pharmaceutical compositions, and synthetic methods for preparing relevant compounds and intermediates.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…